Skip to main content

Table 1 Patient characteristics

From: Accuracy of tumor segmentation from multi-parametric prostate MRI and 18F-choline PET/CT for focal prostate cancer therapy applications

Patient Age (years) PSA at time of biopsy (ng/mL) Time interval between MRI and PET (days) Time interval between imaging and biopsy (days) Time interval from biopsy to prostatectomy (days) Volume of Gleason ≥ 7 disease at pathology (mL) Standard biopsy highest Gleason score Targeted biopsy highest Gleason score Final maximum Gleason score at prostatectomy Number of additional Gleason 3+3 cancers at prostatectomy
1 57 4.6 0 23 63 0.19 3 + 3 3 + 4 3 + 4 4
2 73 4.3 0 21 61 1.35 3 + 4 Negative 3 + 4 6
3 73 4.6 0 15 133 1.35 3 + 3 3 + 4 3 + 4 2
4 60 23.0 19 6 55 3.15 3 + 4 4 + 4 4 + 3 1
5** 64 3.0 0 14 120 0.15 3 + 3 3 + 3 3 + 4 4
6 65 24.4 25 56 99 1.37 Negative 3 + 4 4 + 3 0
7 62 4.6 47 28 146 0.57 Negative 4 + 3 4 + 3 2
8 66 20.4 45 49 106 6.31 3 + 4 4 + 3 4 + 3 0
9 59 4.7 37 35 169 0.91 3 + 3 4 + 5 4 + 5 0
10 66 8.6 35 7 79 3.73 Negative 3 + 4 3 + 4 0
  1. **Excluded from analysis as lesion was not identified by readers